Here’s how investing just £200 a month could create a chunky SIPP portfolio

Our writer shows how investing regularly in a SIPP account can lead to a £1m+ portfolio for savvy investors who start early enough.

| More on:
A senior group of friends enjoying rowing on the River Derwent

Image source: Getty Images

When investing, your capital is at risk. The value of your investments can go down as well as up and you may get back less than you put in.

Read More

The content of this article is provided for information purposes only and is not intended to be, nor does it constitute, any form of personal advice. Investments in a currency other than sterling are exposed to currency exchange risk. Currency exchange rates are constantly changing, which may affect the value of the investment in sterling terms. You could lose money in sterling even if the stock price rises in the currency of origin. Stocks listed on overseas exchanges may be subject to additional dealing and exchange rate charges, and may have other tax implications, and may not provide the same, or any, regulatory protection as in the UK.

You’re reading a free article with opinions that may differ from The Motley Fool’s Premium Investing Services. Become a Motley Fool member today to get instant access to our top analyst recommendations, in-depth research, investing resources, and more. Learn More.

Self-Invested Personal Pensions (SIPPs) offer investors more flexibility and control. Unlike traditional pensions, they allow a wide range of investments, including small-cap stocks, investment trusts, and exchange-traded funds (ETFs). 

Contributions receive tax relief — between 20% and 45%, depending on income — that can also be invested to boost long-term growth.

Over time, this can build a significant pot for retirement, even from modest sums of money.

Should you invest £1,000 in Primary Health Properties right now?

When investing expert Mark Rogers has a stock tip, it can pay to listen. After all, the flagship Motley Fool Share Advisor newsletter he has run for nearly a decade has provided thousands of paying members with top stock recommendations from the UK and US markets. And right now, Mark thinks there are 6 standout stocks that investors should consider buying. Want to see if Primary Health Properties made the list?

See the 6 stocks

Please note that tax treatment depends on the individual circumstances of each client and may be subject to change in future. The content in this article is provided for information purposes only. It is not intended to be, neither does it constitute, any form of tax advice. Readers are responsible for carrying out their own due diligence and for obtaining professional advice before making any investment decisions.

Regular investing

For instance, let’s say a basic-rate taxpayer invests £200 in a SIPP every month. This means they would get another £50 paid in a few weeks later in the form of pension tax relief. The total would therefore amount to £250 per month, or £3,000 per year.

Were they to achieve a 9% average annual return from their investments, this would grow to nearly £160,000 after 20 years.

Keep it going for another decade, the final pot would be £425,790. A significant sum for many people.

The benefits of diversification

Now, I should mention that these calculations don’t include any platform fees or dealing charges. And a 9% return isn’t assured, as stocks can lose value as well as rise. Dividends may also be cut.

The good news is that diversification can go some way to offsetting these risks. For example, owning a few dividend payers would cushion the blow if one cancels its payout, while a basket of growth shares can often make up for one or two that flatter to deceive.

Stock example

To give a real-world example, my own SIPP currently has 21 stocks, as well as a small handful of investment trusts. This means it has a pretty good level of diversification.

That’s a good job because one stock has certainly disappointed recently — Novo Nordisk (NYSE: NVO). Shares of the Danish pharmaceutical giant have cratered 59% in just 10 months in my SIPP!

Created with Highcharts 11.4.3Novo Nordisk PriceZoom1M3M6MYTD1Y5Y10YALL22 Apr 202022 Apr 2025Zoom ▾Jul '20Jan '21Jul '21Jan '22Jul '22Jan '23Jul '23Jan '24Jul '24Jan '252021202120222022202320232024202420252025www.fool.co.uk

Novo is a global leader in diabetes care, controlling around 33% of the market. And through its injectable Ozempic and Wegovy treatments, it also currently has the lion’s share of the fast-growing GLP-1 weight-loss market too.

In Q4, sales of obesity drug Wegovy surged 107% year on year, helping drive net profit 29% higher to almost $4bn. Very strong stuff.

However, arch-rival Eli Lilly recently reported robust Phase 3 results for its oral GLP-1 candidate orforglipron (admittedly a bit of a mouthful!). Lilly says this daily pill will be easier to manufacture, and unlock access for millions of patients who are scared of needles.

It could also erode Novo’s dominant position in the lucrative GLP-1 market. This explains why the stock has shed so much weight and is now trading on a forward price-to-earnings ratio of just 14 — a very low multiple.

At that valuation though, I think the stock is worth considering. This is particularly true given the global anti-obesity drugs market is expected to top $100bn by 2035.

Unfortunately for me though, I’ve backed the wrong weight-loss horse so far.

Still worth it

Despite the risks of manging a DIY pension, I think it’s worth the effort.

For someone starting in their early 20s, the example SIPP above would be worth a whopping £1.64m by the time they retired at 68, assuming the same 9% return and £200 monthly investment.

When combined with a workplace pension, that would certainly make retirement much more comfortable.

Should you invest £1,000 in Primary Health Properties right now?

When investing expert Mark Rogers has a stock tip, it can pay to listen. After all, the flagship Motley Fool Share Advisor newsletter he has run for nearly a decade has provided thousands of paying members with top stock recommendations from the UK and US markets.

And right now, Mark thinks there are 6 standout stocks that investors should consider buying. Want to see if Primary Health Properties made the list?

See the 6 stocks

Should you invest, the value of your investment may rise or fall and your capital is at risk. Before investing, your individual circumstances should be assessed. Consider taking independent financial advice.

Ben McPoland has positions in Novo Nordisk. The Motley Fool UK has recommended Novo Nordisk. Views expressed on the companies mentioned in this article are those of the writer and therefore may differ from the official recommendations we make in our subscription services such as Share Advisor, Hidden Winners and Pro. Here at The Motley Fool we believe that considering a diverse range of insights makes us better investors.

Our best passive income stock ideas

Do you like the idea of dividend income?

The prospect of investing in a company just once, then sitting back and watching as it potentially pays a dividend out over and over?

If you’re excited by the thought of regular passive income payments, as well as the potential for significant growth on your initial investment…

Then we think you’ll want to see this report inside Motley Fool Share Advisor — ‘5 Essential Stocks For Passive Income Seekers’.

What’s more, today we’re giving away one of these stock picks, absolutely free!

Get your free passive income stock pick

More on Investing Articles

Businessman hand flipping wooden block cube from 2024 to 2025 on coins
Investing Articles

I bought 1,779 Legal & General shares 2 years ago – see how much dividend income I’ve got since

Harvey Jones holds Legal & General shares and has been pretty underwhelmed by their performance so far. The dividend is…

Read more »

Middle-aged black male working at home desk
Investing Articles

Is the FTSE 100 set to soar? Here are 3 ways to aim to cash in

My outlook for the FTSE 100 is definitely brightening as we get deeper into 2025. How can we make the…

Read more »

Investing Articles

£10k invested in NatWest shares on the ‘Liberation Day’ dip is today worth…

Harvey Jones looks at how NatWest shares have been knocked off course during recent market turbulence, but are now bouncing…

Read more »

Tariffs and Global Economic Supply Chains
US Stock

£5,000 invested in Nvidia stock just before the tariff news is now worth…

Jon Smith talks through the erratic movements in Nvidia stock over the past six weeks and reveals where an investor…

Read more »

Business manager working at a pub doing the accountancy and some paperwork using a laptop computer
Investing Articles

3 high-yield passive income stocks to consider buying right now

These stocks with big dividend yields look very tempting. Passive income investors could do well to consider taking the plunge.

Read more »

Handsome young non-binary androgynous guy, wearing make up, chatting on his smartphone, carrying shopping bags.
Investing Articles

Is a motley collection of businesses holding back this FTSE 100 stock?

Andrew Mackie explains why he's remained loyal to this FTSE 100 stock despite several of its businesses continuing to struggle…

Read more »

Businessman using pen drawing line for increasing arrow from 2024 to 2025
Investing Articles

3 top growth stocks driving wealth in my Stocks and Shares ISA

Our writer shines a light on a trio of outperforming growth firms in his Stocks and Shares ISA portfolio. They're…

Read more »

Young woman working at modern office. Technical price graph and indicator, red and green candlestick chart and stock trading computer screen background.
Investing Articles

Here’s where analysts expect the Lloyds share price to be a year from now

The Lloyds share price has fared well so far in 2025. But with some big issues on the horizon, can…

Read more »